openPR Logo
Press release

Fluxion Therapeutics Appoints Vince Groppi, Ph.D., to Scientific Advisory Board

01-12-2026 11:06 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Getnews

/ PR Agency: PRChoices
Fluxion Therapeutics Appoints Vince Groppi, Ph.D.,

San Diego, CA, USA - January 12, 2026 - Fluxion Therapeutics, a Physiomics Trademark company, today announced the appointment of Vince Groppi, Ph.D., to its Scientific Advisory Board.

Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg

Dr. Vince Groppi brings over three decades of leadership in neuroscience drug discovery, specialized assay development, and translational biomarkers to Fluxion.

Dr. Groppi's career is defined by foundational contributions to ion channel screening. He was a co-inventor of the FLIPR platform, the industry standard for high-throughput screening (HTS) of ion channels and GPCRs. As CSO at Essen Bioscience, he pioneered planar patch-clamp technology and led the development of IonWorks Trademark HT, the first commercial automated patch-clamp (APC) platform.

Dr. Groppi will provide strategic scientific leadership as the company scales its ScorpION(c) ion channel analytics platform. ScorpION utilizes AI-driven interpretation to streamline complex electrophysiological data, conforming analytics to evolving regulatory requirements for cardiac safety and pro-arrhythmic risk assessment.

"Vince's expertise in bridging the gap between hardware engineering and drug discovery is unmatched," said Eli Black, CEO of Fluxion Therapeutics. "His guidance will be instrumental as we deploy ScorpION(c) to address the 'interpretation bottleneck' in cardiac safety and neuropsychiatric drug development."

"While APC has revolutionized data acquisition, the complexity of data analysis remains a significant barrier to broad adoption in safety pharmacology," said Dr. Groppi. "Fluxion's ScorpION(c) platform addresses this by applying AI to the interpretative layer of APC. I look forward to helping the team deliver these advanced analytics to the global discovery community."

About Fluxion

Fluxion Therapeutics is a U.S.-based leader in AI-driven pre-clinical assay development and screening workflows. The company specializes in omics-scale ion channel data QC and standards, XAI, developing Physiomics Trademark as the missing "fifth Big Omics", and AI integration across trans-omics network analysis and systems biology.
Media Contact
Company Name: Fluxion Therapeutics Inc
Contact Person: Ron Demuth
Email: Send Email [http://www.universalpressrelease.com/?pr=fluxion-therapeutics-appoints-vince-groppi-phd-to-scientific-advisory-board]
Phone: 858-717-2699
Country: United States
Website: https://www.fluxiontherapeutics.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fluxion Therapeutics Appoints Vince Groppi, Ph.D., to Scientific Advisory Board here

News-ID: 4345340 • Views:

More Releases from Getnews

Leavitt & Martin, PLLC Expands Legal Advocacy in Emporia, Virginia
Leavitt & Martin, PLLC Expands Legal Advocacy in Emporia, Virginia
Image: https://www.globalnewslines.com/uploads/2026/02/1770402523.jpg Leavitt & Martin, PLLC, a respected law firm based in Emporia, Virginia, continues to strengthen its commitment to providing high-quality legal representation for clients facing criminal and traffic-related charges. With a focus on strategic defense and personalized legal solutions, the firm remains a trusted resource within the local community. Emporia, VA - Founded on principles of integrity, professionalism, and client-focused service, Leavitt & Martin, PLLC delivers legal guidance designed to
Minumspot Announces February Platform Update Expanding Premium Alcohol Selection and Online Ordering Experience
Minumspot Announces February Platform Update Expanding Premium Alcohol Selection …
Image: https://www.globalnewslines.com/uploads/2026/02/1770401037.jpg Press release visual showing a Jakarta-based digital liquor retail platform with organized wine and whisky collections displayed on a modern e-commerce interface. Minumspot operates a centralized online platform offering a wide range of alcoholic beverages through structured digital access. Jakarta, Indonesia - February 6, 2026 - Minumspot today announced a February platform update that expands its premium alcoholic beverage catalog and introduces improvements to its online ordering experience for customers across
AutobodyShopJobs.com Launches Niche Job Board for Autobody and Metal Finishing Professionals
AutobodyShopJobs.com Launches Niche Job Board for Autobody and Metal Finishing P …
Image: https://www.globalnewslines.com/uploads/2026/02/1770391719.jpg Specialized platform connects shops with skilled finisher technicians across the U.S., offering affordable, targeted job postings. Los Angeles, CA - AutobodyShopJobs.com [https://autobodyshopjobs.com/] is a specialized job posting board dedicated to autobody repair and metal finishing careers. Unlike general job boards, it focuses exclusively on finisher roles, including autobody technicians, picklers, detailers, powder coaters, electroplaters, sandblasters, polishers, collision techs, industrial painters, combo men, resurfacers, paint preppers, and autobody painters. By concentrating
Redefining Valentine's Day: Zeagoo Accompanies Women in Writing Their Own Narrative of Ease Through Everyday Attire
Redefining Valentine's Day: Zeagoo Accompanies Women in Writing Their Own Narrat …
Image: https://www.globalnewslines.com/uploads/2026/02/7b11093c06d9b4dd209de88351208910.jpg As the holiday atmosphere grows, the traditional narrative of Valentine's Day is quietly shifting. No longer confined to candlelit dinners and rose bouquets, more and more women are choosing ways to spend this day that feel closer to their true selves-perhaps enjoying a quiet moment alone with a cup of coffee, sharing a relaxed dinner with friends, or simply continuing their familiar, comfortable routine. In this trend of redefining

All 5 Releases


More Releases for Fluxion

Fluxion Therapeutics and University of Michigan's CCG Partner to Transform Ion C …
Ann Arbor, MI, USA - January 12, 2026 - Fluxion Therapeutics and the Center for Chemical Genomics (CCG) at the University of Michigan have entered a two-year research collaboration to develop artificial intelligence (AI) and machine learning (ML) models for the automated analysis of ion channel electrophysiology. Image: https://www.globalnewslines.com/uploads/2026/01/de3b06a2ea4c13e09455e29926ba7f64.jpg The partnership combines Fluxion's proprietary AI-driven analytics with the CCG's high-throughput screening (HTS) infrastructure. Together, the organizations will develop 'Omics-scale datasets to standardize
Single Cell Analysis Market Projected To Witness Massive Growth, 2025-2032 | Agi …
The Global Single Cell Analysis Market is expected to grow at 6.4% CAGR from 2025 to 2032. The Latest detailed study on the global Single Cell Analysis Market 2025-2032, Outlook is performed by determining industry drivers, dynamics, value chain analysis, prominent investment areas, competitive landscape, regional outlook, and key market segments. It also offers a thorough assessment of the global market's drivers and constraints. The Single Cell Analysis Market report has
Circulating Tumor Cells Market Predicted to Reach $26.61 Billion by 2031 | Therm …
The Global Circulating Tumor Cells Market reached US$ 11.80 billion in 2023 and is expected to reach US$ 26.61 billion by 2031, growing at a CAGR of 11.1% during the forecast period 2024-2031. The Circulating Tumor Cells market report provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead
Global Circulating Tumor Cells Market Size, Status and Forecast 2022 : ApoCell, …
Qyresearchreports include new market research report "Global Circulating Tumor Cells Market Size, Status and Forecast 2022" to its huge collection of research reports. The research report is an idiosyncratic presentation of the diverse segments of the global Circulating Tumor Cells market and the statistics pertaining to the current and historical path of the market’s growth. The chief idea of the market intelligence study is to provide its readers with a presentable
Fluxion Biosciences Inc - Product Pipeline - Global Industry Analysis, Size, Gro …
Fluxion Biosciences Inc is a provider of analytical and live cell analysis tools. “Fluxion Biosciences Inc Product Pipeline” companys products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range of circulating tumor cell and liquid biopsy applications. Fluxion's sequencing assays solutions provide ultra-sensitivity mutation detection from CTCs and cell-free DNA. Request For Free
Fluxion Biosciences Inc Market & Product Pipeline Analysis, 2017 : MRH
Fluxion Biosciences Inc (Fluxion) is a provider of analytical and live cell analysis tools. The companys products include IsoFlux system and CTC kits, BioFlux System, IonFlux System, Cytation CTC imager and enumeration kits, and sequencing kits. It provides analytical services for a range of circulating tumor cell and liquid biopsy applications. Fluxion's sequencing assays solutions provide ultra-sensitivity mutation detection from CTCs and cell-free DNA. The company serves biotech and pharmaceutical